IMU imugene limited

18.2%

1.3¢

Why IMU is a multi multi bagger, page-28280

First 28280 Last

Share
Profile

Follow
Dhm

2,522 Posts.

3809

20/12/24

18:21

Post #: 77143943
Share

Originally posted by Raki: ↑

this is for nextHERIZON study, NCT05311176, good thing is median survival is now 6.93 months in the HER-Vaxx group versus 6.01 months in the chemotherapy alone group, Median OS was 13.9 months in the HER-Vaxx plus chemotherapy group compared to 8.3 months in the chemotherapy alone group, which indicates a 42% survival benefit and about immunogenicity

1. vaccine helped immune system to produce specific proteins called antibodies that target the HER2 protein, this is often found in large amounts on cancer cells. This response was especially strong after patients received three or more doses of the vaccine.

2. antibodies generated by the vaccine were linked to a reduction in tumor size.

3. antibodies acted like "flags," marking the cancer cells so that the body’s immune cells could find and destroy them

4. antibodies produced by the vaccine blocked certain "on" signals in the HER2 protein

5. The vaccine also reduced the number of a specific type of immune-suppressing cells called FOXP3+ T cells that normally protect the cancer. By lowering these cells, the body’s immune system was better able to fight the cancer

so overall this is awesome story line, lets see how this translates to share price appreciation.. this is good, this is good..

Expand

Thanks for the summary. I don't understand this discussion. Raki, you are saying there is new info as constructed in your post above. But @bavarian1975 says last update was in 2023. Yet i found the slide on the Imugene Conference Presentation website showing a date of 12 December 2024. Why didn't Imugene release any new info via an ASX announcement if it is indeed updated results. It's all too hard. I'm going to have a Bex and a good lie down.

https://imugene.com/investors/conference-presentations/

IMU Price at posting: 3.8¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 28280 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.3¢		Change 0.002(18.2%)		Mkt cap ! $97.07M

Open	High	Low	Value	Volume
1.2¢	1.4¢	1.1¢	$625.7K	50.56M

Buyers (Bids)

No.	Vol.	Price($)
20	5795292	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.3¢	3258567	9

View Market Depth

No.	Vol.	Price($)
18	5735292	0.012
35	10497532	0.011
118	35980571	0.010
37	19431668	0.009
13	4220748	0.008

Price($)	Vol.	No.
0.013	3078567	8
0.014	10063029	39
0.015	6593187	20
0.016	6224494	27
0.017	7006978	10

Last trade - 16.10pm 27/06/2025 (20 minute delay)

IMU (ASX) Chart

Why IMU is a multi multi bagger, page-28280

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why IMU is a multi multi bagger, page-28280

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News